|
|
||||||||
INFLAMMATION/IMMUNITY/MEDIATORS
against acute gastric mucosal lesions associated with ischemia-reperfusion
1Department of Pharmacology, School of Dentistry, Osaka University, Osaka 566-0871; 2Gastroenterology Division, Brigham and Women's Hospital and Harvard Medical School, Boston 02115; 3Gastroenterology Division, Yokohama City University, Yokohama 236-0004; 4Department of Internal Medicine, University of Tokyo, Tokyo 113-0033; and 5Section of Gastroenterology, Boston University School of Medicine, Boston, Massachusetts 02118; and 6Pathology Division, National Institute of Health, Tokyo, Japan 162-8640
Submitted 17 December 2003 ; accepted in final form 11 March 2004
Acute gastric mucosal lesions (AGMLs) are an important cause of gastrointestinal bleeding. Herein, we demonstrate that peroxisome proliferator-activated receptor-
(PPAR
), a member of a nuclear receptor family, functions as an endogenous anti-inflammatory pathway in a murine model of AGML induced by ischemia-reperfusion (I/R). Treatment with specific PPAR
ligands such as BRL-49653, pioglitazone, or troglitazone was examined in a model of AGML induced by I/R. PPAR
-deficient and wild-type mice were also examined for their response to I/R in stomach. Specific PPAR
ligands exhibited dramatic and rapid protection against AGML formation associated with I/R in mice in a dose-dependent manner. In contrast, the AGML induced by I/R in PPAR
-deficient mice was more severe than that observed in wild-type mice. Administration of the PPAR
ligand significantly inhibited the upregulation of TNF-
, ICAM-1, inducible nitric oxide synthase, apoptosis, and nitrotyrosine formation induced by I/R in the stomach. These data indicate that an endogenous pathway associated with PPAR
plays an important role in the pathogenesis of I/R-associated injury in the stomach.
peroxisome proliferator-activated receptor-
nitrotyrosine; ICAM-1
This article has been cited by other articles:
![]() |
M. Abdelrahman, A. Sivarajah, and C. Thiemermann Beneficial effects of PPAR-{gamma} ligands in ischemia-reperfusion injury, inflammation and shock Cardiovasc Res, March 1, 2005; 65(4): 772 - 781. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |